Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11008399 Antibodies

Patent 11008399 was granted and assigned to Genmab A/S on May, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
Genmab A/S
Date Filed
October 22, 2020
Date of Patent
May 18, 2021
Patent Applicant
‌
Genmab A/S
Patent Application Number
17077376
Patent Citations
‌
US Patent 10590206 Inert format
‌
US Patent 10344050 Production of heterodimeric proteins
0
‌
US Patent 10407501 Humanized or chimeric CD3 antibodies
0
‌
US Patent 10434184 Anti-TPBG antibodies and methods of use
0
‌
US Patent 10465006 Humanized or chimeric CD3 antibodies
‌
US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof
Patent Citations Received
‌
US Patent 11970544 Antibodies
0
Patent Inventor Names
Rik Rademaker
0
Sjeng Horbach
0
Bart E. C. G. De Goeij
0
David Satijn
0
Dennis Verzijl
0
Edward N. Van Den Brink
0
Esther C. W. Breij
0
Kristel Kemper
0
Patrick Engelberts
0
Paul Parren
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11008399
Patent Primary Examiner
‌
Jessica H Roark

Find more entities like US Patent 11008399 Antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo